Elan to Pay $200 Million to Develop Alzheimer's Drug (Update1)
Bloomberg - USA
... 27 (Bloomberg) -- Elan Corp., the maker of the Tysabri multiple sclerosis treatment, will pay as much as $200 million to add an experimental treatment to its ...

---

Fampridine

StreetInsider.com Pre-Open Movers 09/27
StreetInsider.com (subscription) - Birmingham,MI,USA
... profit taking following today's 29% run-up and yesterday's 283% run-up after announcing positive results from its Phase 3 clinical trial of Fampridine-SR on ...
See all stories on this topic

Acorda Therapeutics "buy," target price raised
newratings.com - USA
... this morning, the analyst mentions that the upward revision in the target price reflects a rise in the probability of the success of Fampridine-SR from 25% to ...
See all stories on this topic

---

Elan to Pay $200 Million to Develop Alzheimer's Drug (Update1)
Bloomberg.com Wed, 27 Sep 2006 4:11 AM PDT
Sept. 27 (Bloomberg) -- Elan Corp., the maker of the Tysabri multiple sclerosis treatment, will pay as much as $200 million to add an experimental treatment to its Alzheimer's disease program.

Vitamin B3 may be useful against MS: animal study Reuters via Yahoo! News Tue, 26 Sep 2006 11:43 AM PDT Boosting concentrations in the nervous system of a vital compound called NAD, by giving its chemical precursor, nicotinamide, a form of vitamin B3, has shown considerable therapeutic potential in a mouse model of multiple sclerosis (MS).

Drug helps some MS victims walk better Lexington Herald-Leader Wed, 27 Sep 2006 0:16 AM PDT An experimental drug for multiple sclerosis is helping some patients walk better, results from a new study show. Scientists at Acorda Therapeutics, in Hawthorne, N.Y., announced their results Monday after finishing analysis of the study over the weekend. Patients on the medicine were walking consistently faster over a 14-week period than those on a placebo. Their leg muscles also seemed stronger.

Free health talks Burlington Post Wed, 27 Sep 2006 9:03 AM PDT Naturopathic medicine and alternative therapies will be the subject of two free seminars hosted by local naturopath Andrea Hornyak next week.

Stem Cell Research Debated at UH Campus: State Legislators Hear From People on All Sides of the Hot-Button Issue RedNova Wed, 27 Sep 2006 6:10 AM PDT By Todd Ackerman, Houston Chronicle Sep. 27--State legislators brought the debate over whether Texas should expand or outlaw embryonic stem cell research to Houston on Tuesday.

NeuroMedix creates Medical and Scientific Advisory Board of distinguished academic and drug development experts to CNW Group via Yahoo! Finance Wed, 27 Sep 2006 5:00 AM PDT NeuroMedix Inc. today announced that it has created a Medical and Scientific Advisory Board panel of experts to help guide the clinical development of Minozac, its lead compound for the treatment of Alzheimer's disease.

Health calendar Gloucester Daily Times Tue, 26 Sep 2006 1:14 PM PDT Chair Yoga, Wednesdays, 12:30 to 1:30 p.m., Rose Baker Senior Center. To register, call Lisa at the Council on Aging at 978-281-9765. Exercises for prevention and treatment of osteoporosis, Wednesdays, 2 to 3 p.m., Rose Baker Senior Center.

Paul Allen hopes brain map will help science KING 5 Seattle Tue, 26 Sep 2006 2:08 PM PDT A map of the mouse brain down to details of individual cells has been completed, the first project of an institute funded by Microsoft Corp. co-founder Paul G. Allen, it was announced Tuesday.

Qualified Canadians Still Able to Access Medical Marijuana from Health Canada CNW Group via Yahoo! Finance Tue, 26 Sep 2006 1:02 PM PDT Yesterday the Conservative government announced spending cuts scheduled over the next two years. Funding for academic medical marijuana research - originally made available through the Medical Marijuana Research Program , established in 2003 - was included in that list.

Seattle Times: 'Brain atlas' mapping brain down to cell level
KING 5 Seattle Tue, 26 Sep 2006 11:38 AM PDT
Seattle researchers backed by billionaire Paul Allen have created a map of a mouse brain down to the details of individual cells. The Allen Institute of Brain Science is putting the Allen Brain Atlas online free to other neuroscientists studying brain circuits and chemistry - and what goes wrong in cancer and other diseases.